// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

An Ethnographic Survey of Maternal Stress in a Ugandan Neonatal Hospital Unit

Delaney Barth - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Antibiogram of bacterial pathogens in neonatal intensive care units in Canada

Joseph Ting - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Brain age estimation from neonatal MRI using deep neural networks

Farzad Beizaee - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Characterizing the Epidemiology of Bloodstream Infections among Hospitalized Neonates in Botswana: Are HIV-exposed neonates protected?

Carolyn M. McGann - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Human immunodeficiency virus infection

Zidovudine

Clinical Pathway Programs in Children’s Hospitals: A North American Survey Study

Leigh Anne Bakel - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Combination therapy for Patent Ductus Arteriosus: Effectiveness and Echocardiographic Changes

Ayman Saker - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Patent ductus arteriosus

Acetaminophen

Comparison of Maternal and Neonatal Outcomes for Periviable PPROM < 20 Weeks versus 20-24 Weeks Gestation: A Systematic Review and Meta-analysis

Maura Helena Ferrari Resende - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Chorioamnionitis

N/A

Compliance with the Golden Hour bundle in deliveries attended by a specialized neonatal transport team compared with staff at non-tertiary centers

Maher Shahroor - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Congenital heart defect newborns with diastolic steal have altered cerebral arterial doppler profile during the transitional period

Marina Mir - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Creatine Kinase Predicts Low Cardiac Output in Neonatal Hypoxic-Ischemic Encephalopathy

Shiran Sara Moore - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hypoxic-ischemic encephalopathy

N/A

Early antimicrobial exposure and weight gain in extremely low gestation age infants without culture-proven sepsis or intestinal pathologies.

Prakesh Shah - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sepsis

N/A

Effectiveness of a Neonatal Intensive Care Unit specific - Antimicrobial Stewardship Program: A 10-year review.

Joseph Ting - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Sepsis

N/A

Effects of a new infant formula with a novel high-quality protein matrix and whole milk on energetic efficiency and gastrointestinal tolerance

Devon Kuehn - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Lactoferrin

Evaluating the Impact of Point of Care Testing in the Emergency Department for Group A Streptococcal Pharyngitis on Clinical Outcomes and Resource Utilization: A Randomized Controlled Trial

Carson Gill - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evaluating virtual family-centered rounds effectiveness, efficiency and usability during COVID-19

Melanie Buba - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Feasibility of Rescue Neurally Adjusted Ventilatory Assist in Very Preterm Infants and Impact on Cardiorespiratory Stability

Eman Hashim - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Hospitalization for Failure to Thrive: A Retrospective Chart Review

Shamini Selvakumar - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Identifying Optimal Endotracheal Tube Size for Neonatal Intubation in the International NEAR4NEOS Database

Patrick J. Peebles - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact and relevance of a second urine culture by mid-stream in suspected urinary tract infection in children: A quality improvement study.

Céline Thémelin - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Urinary tract infections

N/A

Impact of COVID-19 Pandemic on Pediatric Emergency Endotracheal Intubation Practices and Outcomes

Kelsey A. Miller - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Copyright © 2026. QuantiNova All rights reserved